Liquidia Share Price (NASDAQ: LQDA)

$26.84

▲

-0.46

(-1.68%)

Last updated on August 23, 2025 at 1:29 AM IST

$₹

Check the interactive Liquidia Stock chart to analyse performance

Liquidia stock performance

as on August 23, 2025 at 1:29 AM IST

Today's Low:$26.30
Today's High:$27.60
$26.84
2.01%
Downside
Day's Volatility :4.71%
Upside
2.75%
52 Weeks Low:$8.75
52 Weeks High:$28.00
$26.84
67.4%
Downside
52 Weeks Volatility :68.75%
Upside
4.14%

Liquidia Stock Returns

Period	Liquidia Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	71.67%	6.0%	0.0%
6 Months	68.53%	-5.6%	0.0%
1 Year	172.43%	-11.1%	0.0%
3 Years	264.85%	6.8%	-7.8%

Liquidia Corp Key Stats

Check Liquidia key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$27.3
Open	$27.355
Today's High	$27.6
Today's Low	$26.3
Market Capitalization	$2.4B
Today's Volume	$2.6M
52 Week High	$28.0
52 Week Low	$8.75
Revenue TTM	$19.3M
EBITDA	$-136.9M
Earnings Per Share (EPS)	$-1.82
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-389.13%

Stock Returns calculator for Liquidia Stock including INR - Dollar returns

The Liquidia stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Liquidia investment value today

Current value as on today

₹2,73,523

Returns

₹1,73,523

(+173.52%)

Returns from Liquidia Stock

₹1,69,208 (+169.21%)

Dollar Returns*

₹4,316 (+4.32%)

Indian investors sentiment towards Liquidia Stock

-35%

Period: Jul 24, 2025 to Aug 23, 2025. Change in 30 Days versus previous period

Search interest for Liquidia Stock from India on INDmoney has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Liquidia Corp

Name
Holdings %
Name
Holdings %
Caligan Partners LP
9.46%
BlackRock Inc
5.51%
Farallon Capital Management, L.L.C.
4.65%
Vanguard Group Inc
4.19%
Findell Capital Management LLC
3.49%
Opaleye Management Inc
2.88%

Analyst Recommendation on Liquidia Stock

Rating

Trend

Buy

84%Buy

7%Hold

7%Sell

Based on 13 Wall street analysts offering stock ratings for Liquidia(by analysts ranked 0 to 5 stars)

Liquidia Share Price Target

What analysts predicted

Upside of 36.61%

Target:

$36.67

Current:

$26.84

Liquidia share price target is $36.67, a slight Upside of 36.61% compared to current price of $26.84 as per analysts' prediction.

Liquidia Stock Insights

Price Movement
In the last 1 month, LQDA stock has moved up by 50.9%
Increasing Revenue
Revenue is up for the last 3 quarters, 2.91M → 8.83M (in $), with an average increase of 35.6% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -38.36M → -41.57M (in $), with an average decrease of 8.4% per quarter

Liquidia Corp Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$8.1M	↑ 198.2%
Net Income	$-47.6M	↓ 10.45%
Net Profit Margin	-589.48%	↑ 1373.44%

	FY20	Y/Y Change
Revenue	$739.6K	↓ 90.84%
Net Income	$-59.8M	↑ 25.6%
Net Profit Margin	-8.1K%	↓ 7490.63%

	FY21	Y/Y Change
Revenue	$12.9M	↑ 1637.81%
Net Income	$-34.6M	↓ 42.14%
Net Profit Margin	-269.03%	↑ 7811.08%

	FY22	Y/Y Change
Revenue	$15.9M	↑ 23.98%
Net Income	$-41.0M	↑ 18.61%
Net Profit Margin	-257.39%	↑ 11.64%

	FY23	Y/Y Change
Revenue	$17.5M	↑ 9.75%
Net Income	$-78.5M	↑ 91.4%
Net Profit Margin	-448.89%	↓ 191.5%

	FY24	Y/Y Change
Revenue	$14.0M	↓ 19.97%
Net Income	$-130.4M	↑ 66.1%
Net Profit Margin	-931.65%	↓ 482.76%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$3.0M	↓ 34.41%
Net Income	$-40.9M	↑ 49.1%
Net Profit Margin	-1.4K%	↓ 771.29%

	Q2 FY24	Q/Q Change
Revenue	$3.7M	↑ 23.12%
Net Income	$-27.9M	↓ 31.73%
Net Profit Margin	-763.65%	↑ 613.47%

	Q3 FY24	Q/Q Change
Revenue	$4.4M	↑ 21.56%
Net Income	$-23.2M	↓ 17.13%
Net Profit Margin	-520.57%	↑ 243.08%

	Q4 FY24	Q/Q Change
Revenue	$2.9M	↓ 34.42%
Net Income	$-38.4M	↑ 65.71%
Net Profit Margin	-1.3K%	↓ 794.79%

	Q1 FY25	Q/Q Change
Revenue	$3.1M	↑ 6.96%
Net Income	$-38.4M	↓ 0.01%
Net Profit Margin	-1.2K%	↑ 85.65%

	Q2 FY25	Q/Q Change
Revenue	$8.8M	↑ 183.24%
Net Income	$-41.6M	↑ 8.37%
Net Profit Margin	-470.51%	↑ 759.2%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$7.3M	↑ 180.98%

	FY20	Y/Y Change
Profit	$501.9K	↓ 93.09%

	FY21	Y/Y Change
Profit	$9.8M	↑ 1858.58%

	FY22	Y/Y Change
Profit	$13.1M	↑ 33.02%

	FY23	Y/Y Change
Profit	$14.6M	↑ 11.65%

	FY24	Y/Y Change
Profit	$8.1M	↓ 44.4%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$1.2M	↓ 62.7%

	Q2 FY24	Q/Q Change
Profit	$2.2M	↑ 78.13%

	Q3 FY24	Q/Q Change
Profit	$2.9M	↑ 33.1%

	Q4 FY24	Q/Q Change
Profit	$1.6M	↓ 45.79%

	Q1 FY25	Q/Q Change
Profit	$1.6M	↑ 2.56%

	Q2 FY25	Q/Q Change
Profit	$7.5M	↑ 370.68%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-48.3M	↑ 51.69%
Investing Cash Flow	$-1.9M	↑ 112.42%
Financing Cash Flow	$66.4M	↓ 3.52%

	FY20	Y/Y Change
Operating Cash Flow	$-54.1M	↑ 12.14%
Investing Cash Flow	$247.9K	↓ 113.4%
Financing Cash Flow	$63.4M	↓ 4.48%

	FY21	Y/Y Change
Operating Cash Flow	$-34.0M	↓ 37.14%
Investing Cash Flow	$-107.2K	↓ 143.25%
Financing Cash Flow	$26.3M	↓ 58.5%

	FY22	Y/Y Change
Operating Cash Flow	$-28.6M	↓ 16.01%
Investing Cash Flow	$-587.0K	↑ 447.47%
Financing Cash Flow	$65.0M	↑ 146.82%

	FY23	Y/Y Change
Operating Cash Flow	$-41.6M	↑ 45.39%
Investing Cash Flow	$-11.3M	↑ 1823.0%
Financing Cash Flow	$43.2M	↓ 33.43%

	FY24	Y/Y Change
Operating Cash Flow	$-93.4M	↑ 124.77%
Investing Cash Flow	$-8.4M	↓ 25.22%
Financing Cash Flow	$194.7M	↑ 350.11%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-24.9M	↑ 55.59%
Investing Cash Flow	$-624.0K	↑ 202.91%
Financing Cash Flow	$99.7M	↑ 321.58%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-22.7M	↓ 8.87%
Investing Cash Flow	$-1.3M	↑ 106.73%
Financing Cash Flow	$-814.0K	↓ 100.82%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-25.1M	↑ 10.68%
Investing Cash Flow	$-1.7M	↑ 35.43%
Financing Cash Flow	$98.1M	↓ 12152.09%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-20.8M	↓ 17.02%
Investing Cash Flow	$-4.8M	↑ 173.61%
Financing Cash Flow	$-2.3M	↓ 102.34%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-30.7M	↑ 47.4%
Investing Cash Flow	$-330.0K	↓ 93.1%
Financing Cash Flow	$24.3M	↓ 1157.84%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-39.5M	↑ 28.69%
Investing Cash Flow	$-1.1M	↑ 220.3%
Financing Cash Flow	$47.7M	↑ 96.42%

Liquidia Technicals Summary

Sell

Neutral

Buy

Liquidia is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Liquidia Corp Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Liquidia Corp	36.63%	68.53%	172.43%	264.85%	469.79%
Regeneron Pharmaceuticals, Inc.	4.66%	-17.37%	-50.86%	-2.39%	-3.46%
Beone Medicines Ltd	7.62%	21.35%	57.45%	78.28%	25.05%
Vertex Pharmaceuticals Incorporated	-15.87%	-17.97%	-18.14%	35.67%	45.07%
Alnylam Pharmaceuticals, Inc.	38.16%	82.49%	68.79%	112.36%	238.79%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Liquidia Corp	NA	NA	NA	-1.47	-3.89	-0.4	NA	0.18
Regeneron Pharmaceuticals, Inc.	15.08	15.08	1.23	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.29	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	28.25	28.25	0.58	18.06	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Liquidia Corp	Buy	$2.4B	469.79%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$63.4B	-3.46%	15.08	31.37%
Beone Medicines Ltd	NA	$38.2B	25.05%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$101.9B	45.07%	28.25	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$60.1B	238.79%	NA	-12.96%

About Liquidia Corp

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.

Organization	Liquidia
Employees	170
CEO	Dr. Roger A. Jeffs Ph.D.
Industry	Health Technology

Key Management of Liquidia Corp

Name	Title
Dr. Roger A. Jeffs Ph.D.	CEO & Director
Mr. Michael Kaseta	COO & CFO
Mr. Russell Schundler	General Counsel & Corporate Secretary
Ms. Dana Boyle	Chief Accounting Officer
Mr. Christian Perez Font	Senior VP, Chief Compliance Officer & Associate General Counsel
Mr. Michael Post	Senior Vice President of Marketing
Matt Snow	Senior Vice President of Sales
Ms. Sarah Krepp SPHR	Chief Human Resources Officer
Mr. Jason Adair	Chief Business Officer
Mr. Scott Moomaw	Chief Commercial Officer

Important FAQs about investing in LQDA Stock from India :

What is Liquidia share price today?

Liquidia share price today is $26.84 as on August 23, 2025 at 1:29 AM IST at the close of the market. Liquidia share today touched a day high of $27.60 and a low of $26.30.

What is the 52 week high and 52 week low for Liquidia share?

Liquidia share touched a 52 week high of $28.00 and a 52 week low of $8.75. Liquidia stock price today i.e. August 23, 2025 at 1:29 AM IST is closed at $26.84, lower by 4.14% versus the 52 week high.

How to invest in Liquidia Stock (LQDA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Liquidia on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Liquidia Shares that will get you 0.0559 shares as per Liquidia share price of $26.84 per share as on August 23, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Liquidia Stock (LQDA) from India?

Indian investors can start investing in Liquidia (LQDA) shares with as little as ₹87.521 or $1 (as of August 24, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Liquidia stock (as per the Rupee-Dollar exchange rate as on August 24, 2025). Based on Liquidia share’s latest price of $26.84 as on August 23, 2025 at 1:29 AM IST, you will get 0.3726 shares of Liquidia. Learn more about fractional shares .

What are the returns that Liquidia has given to Indian investors in the last 5 years?

Liquidia stock has given 469.79% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?